SCN1A and Dravet syndrome: In support of a deficiency of ECS in DS, the positive allosteric modulation (PAM) of CB1 receptor GAT229 and enhancement of brain 2-AG concentrations using ABX-1431, a MAGL inhibitor, both produced significant anticonvulsant effects against hyperthermia-induced seizures in Scn1a+/− mice [161].